Nexeon Medsystems Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Will Rosellini

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure6.9yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Will Rosellini's remuneration changed compared to Nexeon Medsystems's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2018n/an/a

-US$2m

Jun 30 2018n/an/a

-US$679k

Mar 31 2018n/an/a

-US$1m

Dec 31 2017US$2US$2

-US$2m

Sep 30 2017n/an/a

-US$5m

Jun 30 2017n/an/a

-US$5m

Mar 31 2017n/an/a

-US$2m

Dec 31 2016US$10kn/a

-US$802k

Compensation vs Market: Insufficient data to establish whether Will's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Will's compensation with company performance.


CEO

Will Rosellini (43 yo)

8yrs

Tenure

US$2

Compensation

Mr. William Rosellini, also known as Will, JD, MBA, serves as President of CytoImmune Therapeutics, Inc. He serves as Chairman at Growth Stack, Inc. since August 2020. He served as Principal at Growth Stac...


Board Members

NamePositionTenureCompensationOwnership
William Rosellini
Chairman & CEO8yrsUS$2.00no data
Michael Jaff
Scientific & Clinical Advisorno datano datano data
Juan Parodi
Scientific & Clinical Advisorno datano datano data
William Gray
Scientific & Clinical Advisorno datano datano data
Takao Ohki
Scientific & Clinical Advisorno datano datano data
Eberhart Grube
Scientific & Clinical Advisorno datano datano data
Mark Wholey
Scientific & Clinical Advisorno datano datano data
Stephen Ramee
Scientific & Clinical Advisorno datano datano data
Peter Gaines
Scientific & Clinical Advisorno datano datano data
Gary Ansel
Scientific & Clinical Advisorno datano datano data
Kent George
Independent Director6.9yrsUS$36.68kno data
Michael Neitzel
Independent Director6.9yrsUS$36.68kno data

6.9yrs

Average Tenure

44yo

Average Age

Experienced Board: NXNN's board of directors are considered experienced (6.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.